Optimal Antiplatelet and Lipid Therapy in ACS With DES: OPACT Trial
NA
" Patients with acute coronary syndrome (ACS) undergoing percutaneous coron...
Status
Not Yet Recruiting
Location
Division of Cardiology, Severance Cardiovascular Hospital Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-gu 120-752 Seoul, South Korea
Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)
PHASE3
Primary Objective:
To provide participants with severe hypercholesterolemi...
The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia
PHASE3
A Multi-center, Randomized, Double-blind, Phase III Clinical Trial to Evalu...